1 Min Read
Oct 30 (Reuters) - BAYER AG:
* BAYER RECEIVES FDA APPROVAL FOR XARELTO® 10 MG ONCE DAILY FOR EXTENDED TREATMENT OF VENOUS THROMBOEMBOLISM Source text: www.bit.ly/2z44Vt1 Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.